Skip to main content
Back to Accel

Accel's Biotechnology Portfolio

Browse 6 Biotechnology companies funded by Accel. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
6
Total Funding in Biotechnology
$105.6M

Biotechnology Portfolio Companies (6)

Export
BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics

Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.

New York, United States
April 2026
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHardwareInternet of ThingsManufacturingSoftware

IoT, Biotechnology, Software and Hardware Development

Nicosia, Cyprus
April 2026
$2.6M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyGenetics

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more accessible genomics data.

Sydney, Australia
March 2026
$317K
Grant

Founder Contacts

19,000+ verified contacts

AnalyticsBiotechnologyHealth CareMedical

NanoPhoria develops non-viral, nano-delivery systems for cardiovascular treatments, focusing on inhalable biologics.

Milan, Italy
October 2025
$97.8M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalMedical Device

Liberate Medical licenses a technology that is synchronized with a patient's breathing cycle.

Crestwood, United States
September 2025
$4.5M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer.

Barcelona, Spain
September 2025
$394K
Seed

Founder Contacts

19,000+ verified contacts

Explore Accel's Full Portfolio

View all companies funded by Accel across every industry and funding stage.

View Full Accel Portfolio